Antioxidant and anti-apoptotic effect of melatonin on the vestibular hair cells of rat utricles

Clinical and Experimental Otorhinolaryngology

Volumn 2, Issue 1, 2009, Pages 6-12

  Kim, Jeong Beom ^a   Jung, Jae Yun ^a   Ahn, Jin Chul ^a   Rhee, Chung Ku ^a   Hwang, Hee Jun ^a  

^a Dankook University   (South Korea)

Author keywords

Antioxidants; Melatonin; Ototoxicity; Utricle

Indexed keywords

EID: 68249093624     PISSN: 19768710     EISSN: 20050720     Source Type: Journal    
DOI: 10.3342/ceo.2009.2.1.6     Document Type: Article

References (19)

1. Priuska EM, Schacht J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol. 1995 Nov. 27;50(11):1749-52.
2. Forge A., Li L. Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res. 2000 Jan;139 (1-2):97-115.
3. Forge A., Schacht J. Aminoglycoside antibiotics. Audiol Neurootol. 2000 Jan-Feb;5 (1):3-22.
4. Kroemer G., Petit P., Zamzami N., Vayssiere JL, Mignotte B. The biochemistry of programmed cell death. FASEB J. 1995 Oct;9(13):1277-87.
5. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine. 2005 Jul;27(2): 119-30.
6. Marshall KA, Reiter RJ, Poeggeler B., Aruoma OI, Halliwell B. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med. 1996;21(3):307-15.
7. Costa EJ, Lopes RH, Lamy-Freund MT. Permeability of pure lipid bilayers to melatonin. J Pineal Res. 1995 Oct;19(3):123-6.
8. Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007;13 (1):119-26.
9. Reiter RJ, Acuna-Castroviejo D., Tan DX, Burkhardt S. Free radicalmediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci. 2001 Jun; 939:200-15.
10. Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys. 2001;34(2):237-56.
11. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005 Oct. 1;10(19):1313-21.
12. Darlington CL, Smith PF. Vestibulotoxicity following aminoglycoside antibiotics and its prevention. Curr Opin Investig Drugs. 2003 Jul;4(7): 841-6.
13. Leon J., Acuna-Castroviejo D., Sainz RM, Mayo JC, Tan DX, Reiter RJ. Melatonin and mitochondrial function. Life Sci. 2004 Jul. 2;75(7):765-90.
14. Hardeland R., Reiter RJ, Poeggeler B., Tan DX. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev. 1993 Fall;17(3):347-57.
15. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 1997 Oct. 10;278(5336):294-8.
16. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997 Aug. 15;326 (Pt 1):1-16.
17. Kirsch DG, Doseff A., Chau BN, Lim DS, de Souza-Pinto NC, Hansford R., et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem. 1999 Jul. 23;274(30):21155-61.
18. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004 Jul. 30;305(5684):626-9.
19. Cunningham LL, Matsui JI, Warchol ME, Rubel EW. Overexpression of Bcl-2 prevents neomycin-induced hair cell death and caspase-9 activation in the adult mouse utricle in vitro. J Neurobiol. 2004 Jul;60 (1): 89-100.